Evaluation of the effect on Oral Administration of PAVANAK KATUKKAY along with THUMBAI NEI Nasiyam in the Management of NASIKAPEEDAM in Padiatric age group.

Preclinical and Clinical Evaluation of The Effect on Oral Administration of PAVANAK KATUKKAY along with THUMBAi NEI NASIYAM in the Management of NASIKAPEEDAM (NASAL POLYP) in Paediatric age group (5 TO 12 years). - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063358

Enrollment

Registered

2024-02-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J33- Nasal polyp

Interventions

Intervention1: PAVANAK KATUKKAY (Internal Administration) Thumbai nei(Nasiyam): Internal medicine should be administrated orally twice a day after food intake.Dosage(according age of the patient) 500m

Eligibility

Inclusion criteria

Inclusion criteria: Nasal congestion Nasal discharge Facial pain Nasal polyp Difficulty in breathing

Exclusion criteria

Exclusion criteria: Nasal septum deviation. Sinonasal retention cyst Allergic fungal sinusitis Nasal lymphoma

Design outcomes

Primary

Measure	Time frame
This study will help to understand the effects of PAVANAK KATUKKAY and THUMBAI NEI in the management of NASIKAPEEDAM and may provide a better improvement in health care of children.Timepoint: 2 years	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr K Shyamala MD S

Government Siddha Medical College, Palayamkottai, Tirunelveli.

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026